NewLake Capital Partners, Inc. (NLCP) Stock Analysis

NLCP combines defensive triple-net real estate cash flows with high regulatory optionality in U.S. cannabis. Despite 100% rent collection from performing tenants, no significant debt maturities until 2027, and a dividend yielding ~11.4%, the stock trades at distressed-like multiples—attributed in the report to a “regulatory illiquidity discount” from federal illegality that forces OTCQX trading and blocks broad institutional participation. In 2024–2025’s sector “capital famine,” NLCP delivered stable revenue (YTD 2025 $38.7M, +3% YoY), growing FFO/AFFO and consistent estimate beats, while maintaining a $0.43 quarterly dividend ($1.72 annualized) at ~82% AFFO payout. Looking into 2026, outcomes are framed as more binary and catalyst-driven: Schedule III rescheduling (and 280E removal) plus a potential uplisting could trigger a major valuation re-rating, while operationally the key test is managing tenant credit stress (AYR liquidity issues; Revolutionary Clinics vacancy). The report’s stance is High-Conviction Buy for income plus speculative upside, with downside buffered by real-asset NAV (~$21/share) and liquidity ($23.6M cash; $106M total liquidity).